Trials / Withdrawn
WithdrawnNCT02033590
Clinical and Economic Outcomes With the Use of SERI® Surgical Scaffold in Direct-to-implant Breast Reconstruction
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sofregen Medical, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to prospectively observe clinical and economic outcomes with the use of SERI® in direct-to-implant breast reconstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Biodegradable (purified) surgical silk scaffold |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-07-01
- Completion
- 2014-08-01
- First posted
- 2014-01-13
- Last updated
- 2017-10-09
Source: ClinicalTrials.gov record NCT02033590. Inclusion in this directory is not an endorsement.